Dear EMWA members,

We are happy to share with you Medical Writing December 2023 issue on Biotechnology.

Guest edited by Jennifer Bell, this issue reveals the many faces of Biotechnology and highlights the crucial role of writing and communications in this scientific field. Great end-of-the-year reading material!

And here’s what we have planned for 2024:

March 2024: Translation

Medical translation is a complex and demanding field requiring specialised knowledge, skills, and expertise. In this issue, we explore a range of topics, including the role of medical translation in clinical trials and regulatory affairs, the importance of terminology management, the use of technology and machine translation, ethical and legal considerations, the impact of cultural differences, quality assurance and risk management, and the emerging trends and challenges in the field.

Guest Editors: Ana Sofia Correia and Claire Harmer

The deadline for feature articles is December 1, 2023.

June 2024: Soft Skills for Medical Writers

Medical writing is a highly specialised field that requires a unique combination of technical knowledge, writing skills, and soft skills to produce high-quality work. While technical knowledge and writing skills are undoubtedly important, it is how one interacts with people that can truly set medical writers apart and enable them to succeed in their careers. This issue will focus on how soft skills are used within the different areas of the medical writing industry, and we hope it will provide valuable insights and inspiration for medical writers at all stages of their careers.

Guest Editors: Clare Chang and Nicole Bezuidenhout

The deadline for feature articles is March 1, 2024.

September 2024: Clinical Trial Transparency and Disclosure

The clinical trial transparency and disclosure space continues to grow at pace. With the EU Clinical Trial Regulation being applicable since the 2022 launch of the Clinical Trials Information System comes increased requirements for public-facing documents. Provision of a summary of clinical trial results in lay language is also now mandatory in the EU. Challenges continue in balancing protection of personal data of trial participants with transparency, especially in the wake of the COVID-19 pandemic. All of these bring opportunities for medical writers to drive best practice in authoring clinical trial documents with disclosure in mind.

Guest Editors: Holly Hanson and Alison McIntosh

The deadline for feature articles is June 1, 2024.

Take note of the journal paperless option

Our journal is available electronically and can be read online or downloaded as pdf. If you want to explore the green paperless MEW experience, you can opt out of receiving the paper copy of the journal in your EMWA profile under “Preferences.”

We continue to receive plenty of high-quality articles, but we are always happy to get more. Also, the EMWA Creative Team can provide support in creating graphics and visuals for your articles.

Contact us at mew@emwa.org.

Raquel Billiones

Editor-in-Chief, Medical Writing